Kailera Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Kailera Therapeutics, Inc. has filed 56 SEC EDGAR filings since 19 Dec 2025

SEC filing history

Showing 1-25 of 56 matching filings.

Per page
25
Current page
1
SCHEDULE 13G File 005-95629

SCHEDULE 13G filing

Filing date
05 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jul 2026
Reporting date
06 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
08 Jul 2026
Reporting date
29 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2026
Reporting date
09 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-95629

SCHEDULE 13D filing

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-95629

SCHEDULE 13D filing

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .